BETA BIONICS INC (BBNX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BBNX • US08659B1026

14.12 USD
-0.66 (-4.47%)
At close: Feb 11, 2026
14.12 USD
0 (0%)
After Hours: 2/11/2026, 8:07:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

BBNX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for BBNX as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, BBNX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year BBNX has reported negative net income.
  • BBNX had a negative operating cash flow in the past year.
BBNX Yearly Net Income VS EBIT VS OCF VS FCFBBNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • BBNX has a Return On Assets of -23.59%. This is comparable to the rest of the industry: BBNX outperforms 50.00% of its industry peers.
  • BBNX has a Return On Equity of -26.41%. This is comparable to the rest of the industry: BBNX outperforms 59.14% of its industry peers.
Industry RankSector Rank
ROA -23.59%
ROE -26.41%
ROIC N/A
ROA(3y)-86.31%
ROA(5y)N/A
ROE(3y)-215.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BBNX Yearly ROA, ROE, ROICBBNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • BBNX has a Gross Margin (54.51%) which is in line with its industry peers.
  • The Profit Margin and Operating Margin are not available for BBNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BBNX Yearly Profit, Operating, Gross MarginsBBNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • BBNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BBNX has about the same amout of shares outstanding than it did 1 year ago.
  • BBNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BBNX Yearly Shares OutstandingBBNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
BBNX Yearly Total Debt VS Total AssetsBBNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

  • BBNX has an Altman-Z score of 10.02. This indicates that BBNX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.02, BBNX belongs to the top of the industry, outperforming 89.78% of the companies in the same industry.
  • BBNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.02
ROIC/WACCN/A
WACC9.82%
BBNX Yearly LT Debt VS Equity VS FCFBBNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • BBNX has a Current Ratio of 10.64. This indicates that BBNX is financially healthy and has no problem in meeting its short term obligations.
  • BBNX's Current ratio of 10.64 is amongst the best of the industry. BBNX outperforms 93.55% of its industry peers.
  • BBNX has a Quick Ratio of 9.83. This indicates that BBNX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BBNX (9.83) is better than 93.01% of its industry peers.
Industry RankSector Rank
Current Ratio 10.64
Quick Ratio 9.83
BBNX Yearly Current Assets VS Current LiabilitesBBNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for BBNX have decreased strongly by -24.17% in the last year.
  • BBNX shows a strong growth in Revenue. In the last year, the Revenue has grown by 442.93%.
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)442.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, BBNX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.42% on average per year.
  • Based on estimates for the next years, BBNX will show a very strong growth in Revenue. The Revenue will grow by 39.42% on average per year.
EPS Next Y7.15%
EPS Next 2Y7.11%
EPS Next 3Y4.64%
EPS Next 5Y9.42%
Revenue Next Year51.43%
Revenue Next 2Y42.9%
Revenue Next 3Y39.35%
Revenue Next 5Y39.42%

3.3 Evolution

BBNX Yearly Revenue VS EstimatesBBNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
BBNX Yearly EPS VS EstimatesBBNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BBNX. In the last year negative earnings were reported.
  • Also next year BBNX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BBNX Price Earnings VS Forward Price EarningsBBNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BBNX Per share dataBBNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.11%
EPS Next 3Y4.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BBNX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BETA BIONICS INC

NASDAQ:BBNX (2/11/2026, 8:07:41 PM)

After market: 14.12 0 (0%)

14.12

-0.66 (-4.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners109.87%
Inst Owner Change0.78%
Ins Owners0.62%
Ins Owner Change-0.17%
Market Cap621.56M
Revenue(TTM)88.57M
Net Income(TTM)-77.84M
Analysts86.25
Price Target29.95 (112.11%)
Short Float %14.18%
Short Ratio4.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.14%
Min EPS beat(2)14.89%
Max EPS beat(2)25.39%
EPS beat(4)2
Avg EPS beat(4)-130.42%
Min EPS beat(4)-470.41%
Max EPS beat(4)25.39%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.6%
Min Revenue beat(2)11.46%
Max Revenue beat(2)15.74%
Revenue beat(4)3
Avg Revenue beat(4)7.72%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)15.74%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.66%
PT rev (3m)15.6%
EPS NQ rev (1m)-1.94%
EPS NQ rev (3m)-0.44%
EPS NY rev (1m)2.06%
EPS NY rev (3m)2.57%
Revenue NQ rev (1m)3.91%
Revenue NQ rev (3m)3.91%
Revenue NY rev (1m)1.15%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.02
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.11
EV/EBITDA N/A
EPS(TTM)-4.37
EYN/A
EPS(NY)-1.81
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.29
OCFYN/A
SpS2.01
BVpS6.7
TBVpS6.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.59%
ROE -26.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.51%
FCFM N/A
ROA(3y)-86.31%
ROA(5y)N/A
ROE(3y)-215.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 915.51%
Cap/Sales 4.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.64
Quick Ratio 9.83
Altman-Z 10.02
F-Score6
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)128.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)146.62%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y7.15%
EPS Next 2Y7.11%
EPS Next 3Y4.64%
EPS Next 5Y9.42%
Revenue 1Y (TTM)442.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year51.43%
Revenue Next 2Y42.9%
Revenue Next 3Y39.35%
Revenue Next 5Y39.42%
EBIT growth 1Y-26.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.87%
EBIT Next 3Y-10.38%
EBIT Next 5Y0.31%
FCF growth 1Y-57.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.78%
OCF growth 3YN/A
OCF growth 5YN/A

BETA BIONICS INC / BBNX FAQ

What is the fundamental rating for BBNX stock?

ChartMill assigns a fundamental rating of 4 / 10 to BBNX.


What is the valuation status of BETA BIONICS INC (BBNX) stock?

ChartMill assigns a valuation rating of 0 / 10 to BETA BIONICS INC (BBNX). This can be considered as Overvalued.


What is the profitability of BBNX stock?

BETA BIONICS INC (BBNX) has a profitability rating of 1 / 10.


What is the expected EPS growth for BETA BIONICS INC (BBNX) stock?

The Earnings per Share (EPS) of BETA BIONICS INC (BBNX) is expected to grow by 7.15% in the next year.